Navigation Links
AMICAS Reports Financial Results for the Fourth Quarter and Year Ended December 31, 2007
Date:2/28/2008

of discontinued

operations, net of taxes of $230 - - - 230

Net loss $(902) $(1,146) $(862)$(1,024)

Loss per share

Basic:

Continuing operations $(0.02) $(0.03) $(0.02) $(0.03)

Discontinued operations 0.00 0.00 0.00 0.00

$(0.02) $(0.03) $(0.02) $(0.03)

Diluted:

Continuing operations $(0.02) $(0.03) $(0.02) $(0.03)

Discontinued operations 0.00 0.00 0.00 0.00

$(0.02) $(0.03) $(0.02) $(0.03)

Weighted average number of shares

outstanding:

Basic 44,746 45,135 44,657 46,499

Diluted 44,746 45,135 44,657 46,499

(a) - includes $30,000, $107,000, $17,000 and $54,000 in stock-based

compensation expense for the three and twelve months ended

December 31, 2007 and December 31, 2006, respectively.

(b) - includes $0.2 million, $1.5 million, $0.3 million and $1.5 million

in stock-based compensation expense for the three and twelve months

ended December 31, 2007 and December 31, 2006, respectively

(c) - includes $67,000, $267,000, $55,000 and $196,000 in stock-based

compensation expense for the three and twelve months ended

December 31, 2007 and December 31, 2006, respectively.

CONDENSED Consolidated Statements Of Cash Flows

(in thousands)

Twelve Months

Ended

December 31,


'/>"/>

SOURCE AMICAS, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AMICAS Schedules Fourth Quarter and 2007 Year End Earnings Results Conference Call
2. AMICAS to Present at UBS Global Healthcare Services Conference
3. MedQuest Standardizes on AMICAS Vision Series PACS
4. AMICAS Solutions Closing the Loop in Radiology Communications
5. AMICAS Transforms Critical Results Notification with RadStream
6. AMICAS Launches Vision Reach 2.0, a Tool to Help Radiology Businesses Grow
7. Webcast Alert: AMICAS, Inc. Announces 3rd Quarter 2007 Earnings Conference Call
8. Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider
9. AMICAS Schedules Third Quarter Earnings Call
10. AMICAS to Present at William Blair & Company Small Cap Growth Stock Conference
11. AMICAS Hosts Complimentary DRA Education Session Featuring Timothy Trysla
Post Your Comments:
*Name:
*Comment:
*Email:
Breaking Medicine Technology:Nearly 100 HIV/AIDS Drugs and Vaccines in Development Pipeline 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 2New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 3New Analytical Training Lab Standardizes on Waters Innovative Technologies to Achieve Educational Goals 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 2China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 3China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 4China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 5China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 6China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 7China Yongxin Pharmaceuticals, Inc. Announces Results for the Third Quarter Ended September 30, 2009 8FDA Acknowledges Mistakes in Knee Device Approval 58323 1FDA Acknowledges Mistakes in Knee Device Approval 58323 2Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 1Brookhaven Labs Joanna Fowler to be awarded National Medal of Science 58320 2Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 1Research network based at University of Toronto gets 245 million boost to speed up cancer detection 10104 2